Sort
25,944 grants matching “neurodegeneration”
BMAL1/ARNTL plays a critical, non-circadian role in secondary tissue damage after contusive SCI
$513,423Michal Hetman · University Of Louisville · R01 · FY2020 · NS
BMAL1/ARNTL plays a critical, non-circadian role in secondary tissue damage after contusive SCI
$513,423Michal Hetman · University Of Louisville · R01 · FY2021 · NS
Evaluating Mechanisms and Therapeutic Potential of (GLP-1R) Agonists for Glaucoma Treatment
$513,342Qi Nannan Cui · University Of Pennsylvania · R01 · FY2023 · EY
Neuroprotection by IFN-beta in AIDS
$513,304Marcus Kaul · University Of California Riverside · R01 · FY2019 · MH
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
$513,256Jeffrey Scott Wefel · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · NR
A TFEB and V-ATPase-mediated lysosomal stress sensing pathway in tauopathy
$513,147Hui Zheng · Baylor College Of Medicine · P01 · FY2022 · AG
A Longitudinal Analysis Stream for FreeSurfer
$513,144Bruce Fischl · Massachusetts General Hospital · R01 · FY2016 · NS
Understanding Amyloid Pathology - Multiomic Activity Imaging of Plaque Formation Dynamics (AmyMAP)
$513,087Jeffrey Nicholas Savas · Northwestern University At Chicago · R01 · FY2025 · AG
TRACKING NEURODEGENERATION IN EARLY WOLFRAM SYNDROME
$513,084Tamara G Hershey · Washington University · R01 · FY2013 · HD
Mechanisms of spreading proteinopathy in Lewy Body Dementia
$513,078Vivek Unni · Oregon Health & Science University · R01 · FY2025 · NS
Mechanisms of spreading proteinopathy in Lewy Body Dementia
$513,078Vivek Unni · Oregon Health & Science University · R01 · FY2024 · NS
In vivo characterization of the PET pharmacokinetic properties of T807 in humans
$513,063Julie C. Price · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AG
A Beta Vaccination: Mechanisms and Therapautic Impact
$513,002J. David Gladstone Institutes · R01 · FY2001 · NS
HTS to identify small molecules to disrupt abnormal huntingtin interactions in HD
$512,946Nancy A Muma · University Of Kansas Lawrence · R01 · FY2016 · NS
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
$512,856Julie A Schneider · Columbia University Health Sciences · U19 · FY2023 · AG
Mechanisms of Toxicity in C. elegans Models of Transthyretin Amyloidosis
$512,714Sandra E Encalada · Scripps Research Institute, The · R01 · FY2018 · AG
Molecular and genetic studies of NMNAT2 in neuroprotection
$512,710Hui-Chen Lu · Trustees Of Indiana University · R01 · FY2023 · NS
Mechanisms of motor neuron toxicity in Kennedy disease
$512,581Andrew P Lieberman · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
SARM1 functional polymorphisms and their contribution to ALS risk
$512,555Adam Joseph Bloom · Washington University · R01 · FY2021 · NS
Exploring the contribution of astrocytes to Huntington disease
$512,502Michelle Gray · University Of Alabama At Birmingham · R01 · FY2020 · NS
Neuronal quality control and neuroprotection in tauopathies
$512,425Charleen T Chu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG
Neuronal quality control and neuroprotection in tauopathies
$512,425Charleen T Chu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Mechanisms of Polyglutamine Neurodegeneration
$512,357Henry L Paulson · University Of Michigan At Ann Arbor · R01 · FY2012 · NS
SSH1-Nrf2 nexus in tipping the balance between degeneration and protection in tauopathies.
$512,136David E Kang · Case Western Reserve University · R01 · FY2024 · AG
RNA-based regulation of TDP-43 nuclear export in ALS/FTD
$511,899Lindsey Renae Hayes · Johns Hopkins University · R01 · FY2022 · NS